Autosomal recessive cerebellar ataxia
MONDO:0015244Autosomal recessive cerebellar ataxias (ARCA) are a heterogeneous group of rare neurological disorders involving both the central and peripheral nervous system (and in some cases other systems and organs), and characterized by degeneration or abnormal development of the cerebellum and spinal cord and, in most cases, early onset occurring before the age of 20 years.
Also known as: ARCA, arca, cerebellar ataxia, autosomal recessive
90 clinical trials for this condition and its sub-types, 0 tagged with Autosomal recessive cerebellar ataxia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Autosomal recessive cerebellar ataxia
-
Autosomal recessive degenerative and progressive cerebellar ataxia 0 trials · 49 incl. sub-types
7 sub-types
- Friedreich ataxia 37 trials Sub-types →
- Marinesco-Sjogren syndrome 10 trials
- FLVCR1-related retinopathy with or without ataxia 0 trials · 1 incl. sub-types Sub-types →
- Mitochondrial DNA depletion syndrome 7 (hepatocerebral type) 1 trial
- Congenital cataracts-facial dysmorphism-neuropathy syndrome 0 trials
- Early-onset cerebellar ataxia with retained tendon reflexes 0 trials
- Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome 0 trials
-
Autosomal recessive metabolic cerebellar ataxia 0 trials · 10 incl. sub-types
7 sub-types
- Cerebrotendinous xanthomatosis 6 trials
- Abetalipoproteinemia 2 trials
- Recessive mitochondrial ataxia syndrome 2 trials
- Familial isolated deficiency of vitamin E 1 trial
- Autosomal recessive ataxia due to PEX10 deficiency 0 trials
- Autosomal recessive cerebellar ataxia - pyramidal signs - nystagmus - oculomotor apraxia syndrome 0 trials Sub-types →
- Autosomal recessive cerebellar ataxia with late-onset spasticity 0 trials
-
Autosomal recessive congenital cerebellar ataxia 0 trials · 7 incl. sub-types
7 sub-types
- Cerebellar ataxia, intellectual disability, and dysequilibrium 5 trials Sub-types →
- Joubert syndrome and related disorders 0 trials · 2 incl. sub-types Sub-types →
- CAMOS syndrome 0 trials
- Cayman type cerebellar ataxia 0 trials
- Autosomal recessive spinocerebellar ataxia 17 0 trials
- Autosomal recessive spinocerebellar ataxia 2 0 trials
- Congenital cerebellar ataxia due to RNU12 mutation 0 trials
-
Autosomal recessive syndromic cerebellar ataxia 0 trials · 2 incl. sub-types
7 sub-types
- Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome 2 trials
- Gemignani syndrome 0 trials
- Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome 0 trials
- Ataxia - oculomotor apraxia type 4 0 trials
- Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome 0 trials
- Autosomal recessive spinocerebellar ataxia 11 0 trials
- Peroxisome biogenesis disorder 4B 0 trials
-
Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 0 trials · 2 incl. sub-types
-
Lichtenstein-Knorr syndrome 0 trials
-
RIDDLE syndrome 0 trials
-
3 sub-types
Most studied deeper sub-types
-
Can diet and vitamin c supercharge rectal cancer treatment?
Disease control Not yet recruitingThis phase 2 trial is investigating whether adding a ketogenic diet and/or high-dose intravenous vitamin C to standard chemoradiotherapy and immunotherapy can improve outcomes for patients with locally advanced rectal cancer that is mismatch repair proficient (pMMR/MSS). The stud…
Phase 2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Experimental drug aims to halt rare neurological decline
Disease control Not yet recruitingThis Phase 3 trial tests whether vatiquinone can slow the progression of Friedreich's ataxia, a rare genetic disorder that damages the nervous system and impairs movement. About 120 adults with moderate symptoms will take the drug for 24 months. Researchers will measure changes i…
Phase 3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could a simple gel boost gum healing in diabetes?
Disease control Not yet recruitingThis study tests whether adding hyaluronic acid gel to standard deep cleaning (scaling and root planing) improves gum healing in people with both diabetes and advanced gum disease. Twenty-three participants will receive the standard cleaning on all teeth, and then two gum pockets…
Sponsor: Marmara University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New combo therapy aims to spare organs in High-Risk rectal cancer
Disease control Not yet recruitingThis phase 3 trial tests whether short-course radiation followed by chemotherapy and an immunotherapy drug (serplulimab) works better than standard long-course chemoradiation for high-risk locally advanced rectal cancer. 612 patients will be randomly assigned to one of the two tr…
Phase 3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can intense walking training help brain injury patients walk better?
Symptom relief Not yet recruitingThis study looks at whether high-intensity walking training can help people with cerebellar damage (a part of the brain that controls balance and coordination) improve their walking ability. Twenty participants will either do intense walking exercises or standard training. The go…
Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Exercise and drug combo may fight fatigue in rare disease
Symptom relief Not yet recruitingThis study looks at whether doing aerobic exercise at home, with or without the drug omaveloxolone, can safely improve fatigue and heart-lung fitness in people with Friedreich's ataxia. About 30 adults with the condition will take part. The goal is to see if the combination helps…
Sponsor: Scott Barbuto • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Video games and AI join the fight against a rare movement disorder
Knowledge-focused Not yet recruitingThis study is testing whether a new digital tool—using AI-powered video games and a single camera—can accurately measure movement problems in people with Friedreich ataxia, a rare inherited condition that affects balance and coordination. Participants play short movement-based co…
Sponsor: University of Exeter • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
AI vs. experts: can a computer judge speech as well as a human?
Knowledge-focused Not yet recruitingThis study will compare how well an AI program (Blings) measures speech clarity in 40 adults with speech disorders from stroke or other neurological conditions. Two speech therapists will also rate the same speech samples. The goal is to see if the AI can reliably replace or assi…
Sponsor: Pusan National University Yangsan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC